CXCL12 and reticulum cell sarcoma: Cellularly, both have been shown to potently inhibit SDF-1 mediated cell migration of human histiocytic lymphoma U937 cells and cell signaling mediated by SDF-1/CXCR4 such as activation of phospho-ERK and phospho-AKT.